Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Change in Accrued Expenses (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Change in Accrued Expenses of $75.51 million for Q3 2026, up 8.3% from $69.75 million a year earlier and up 13.3% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Change in Accrued Expenses (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Amneal Pharmaceuticals was $36.17 million, down 47.6% year-over-year; for FY2025, it came in at $21.32 million, down 90.9% from FY2024.

  • Annual Change in Accrued Expenses shows a five-year compound annual growth rate of 133.5% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Change in Accrued Expenses was $235.14 million in FY2024, -$94.45 million in FY2023, $109.57 million in FY2022 and -$43.93 million in FY2021.
  • The Q3 2026 figure stands as the highest quarterly Change in Accrued Expenses since Q2 2022.
  • On a year-over-year basis, Change in Accrued Expenses increased in three of the last five quarters, with growth averaging 1.5%.
  • The strongest year-over-year quarter for Change in Accrued Expenses in the past five years was Q3 2025, with growth of 48.9%; the weakest was Q2 2023, with a decline of 86.8%.
  • According to Business Quant data, Change in Accrued Expenses for the three prior quarters was $66.66 million (Q2 2026), -$124.58 million (Q1 2026) and $18.58 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 983.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 75.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 75.51 Mn
Jun 30, 2026 66.66 Mn
Mar 31, 2026 -124.58 Mn
Dec 31, 2025 18.58 Mn
Sep 30, 2025 69.75 Mn
Jun 30, 2025 45.62 Mn
Mar 31, 2025 -112.63 Mn
Dec 31, 2024 66.26 Mn
Sep 30, 2024 46.85 Mn
Jun 30, 2024 59.85 Mn
Mar 31, 2024 62.17 Mn
Dec 31, 2023 -19.76 Mn
Sep 30, 2023 33.08 Mn
Jun 30, 2023 42.72 Mn
Mar 31, 2023 -150.48 Mn
Dec 31, 2022 -55.87 Mn
Sep 30, 2022 -108.51 Mn
Jun 30, 2022 322.72 Mn
Mar 31, 2022 -48.78 Mn
Dec 31, 2021 -11.11 Mn
API Access

Amneal Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AMRX&period=max&api_key=YOUR_API_KEY